Literature DB >> 12142245

Endothelin-1 receptors and biosynthesis in the corpus luteum: molecular and physiological implications.

Rina Meidan1, Nitzan Levy.   

Abstract

Endothelin-1 (ET-1), a 21-amino acid peptide was initially identified as a potent vasoconstrictor, ET-1 plays an important role in the female reproductive cycle: its quick ascent during luteal regression, ability to inhibit steroidogenesis in vitro and in vivo, combined with the observation that the luteolytic effects of prostaglandin F2alpha (PGF2alpha) were delayed by pretreatment with ET-1 receptors type A (ETA) antagonists suggest that this peptide functions as an important element of the luteolytic cascade. The observation that ETA receptor expression was inversely correlated with steroidogenesis in luteal cells; namely factors which stimulated steroidogenesis inhibited ETA receptor levels is also in accord with the inhibitory role of ET-1 in corpus luteum (CL) function. Contrary to the mature mid cycle CL, the CL of early cycle is refractory to PGF2alpha-induced luteolysis. PGF2alpha administered at early luteal phase (day 4 of the cycle) failed to increase luteal ET-1 gene expression or its ETA receptors. In contrast, both genes were markedly induced in mid cycle CL exposed to PGF2alpha. ET-1 gene is transcribed as prepro ET-1 (ppET-1) and the active form of peptide is derived from the inactive intermediate big ET-1, by endothelin-converting enzyme-1 (ECE-1), therefore alterations in mature ET-1 levels can be achieved by modulating the expression of ppET-1 and/or ECE-1. Analysis using in situ hybridization and enriched luteal cell subpopulations showed that both steroidogenic and endothelial cells of the CL expressed high levels of ECE-1 mRNA. The ppET-1 mRNA, on the other hand, was only expressed by resident endothelial cells, suggesting that luteal parenchymal and endothelial cells cooperate in the biosynthesis of mature bioactive ET-1. A significant, four-fold elevation in ECE-1 expression (mRNA and protein levels) occurred during the transition of the CL from early to mid luteal phase. This increase was accompanied by a significant rise in ET-1 peptide. Surprisingly however, ppET-1 mRNA levels remained similar during early and mid luteal phase. Collectively, these studies demonstrate that: (a) the various components of ET-1 system (ET-1/ECE-1/ETA) are dynamically and independently regulated during bovine luteal life span. (b) The CL becomes PGF2alpha-responsive only when both ppET-1 and ECE-1 genes are expressed at a level which enable an uninterrupted ET-1 biosynthesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142245     DOI: 10.1016/s0739-7240(02)00164-9

Source DB:  PubMed          Journal:  Domest Anim Endocrinol        ISSN: 0739-7240            Impact factor:   2.290


  7 in total

1.  Endothelin B receptor is not required but necessary for finite regulation of ovulation.

Authors:  Jongki Cho; Heyyoung Kim; Dong-Wook Kang; Masashi Yanagisawa; CheMyong Ko
Journal:  Life Sci       Date:  2012-03-03       Impact factor: 5.037

2.  Endothelin type A receptor (ETA) expression is regulated by HOXA10 in human endometrial stromal cells.

Authors:  Ivan A Penna; Amanda N Kallen; Hugh S Taylor
Journal:  Reprod Sci       Date:  2010-05       Impact factor: 3.060

3.  Tumor and reproductive traits are linked by RNA metabolism genes in the mouse ovary: a transcriptome-phenotype association analysis.

Authors:  Ulises Urzúa; Garrison A Owens; Gen-Mu Zhang; James M Cherry; John J Sharp; David J Munroe
Journal:  BMC Genomics       Date:  2010-12-22       Impact factor: 3.969

4.  Loss of function of endothelin-2 leads to reduced ovulation and CL formation.

Authors:  Joseph A Cacioppo; Sang Wook Oh; Hey-young Kim; Jongki Cho; Po-Ching Patrick Lin; Masashi Yanagisawa; CheMyong Ko
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

Review 5.  Cytokines and angiogenesis in the corpus luteum.

Authors:  António M Galvão; Graça Ferreira-Dias; Dariusz J Skarzynski
Journal:  Mediators Inflamm       Date:  2013-06-11       Impact factor: 4.711

Review 6.  Microvascular endothelial cells of the corpus luteum.

Authors:  John S Davis; Bo R Rueda; Katherina Spanel-Borowski
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

Review 7.  New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides.

Authors:  Ewa Mlyczyńska; Marta Kieżun; Patrycja Kurowska; Monika Dawid; Karolina Pich; Natalia Respekta; Mathilde Daudon; Edyta Rytelewska; Kamil Dobrzyń; Barbara Kamińska; Tadeusz Kamiński; Nina Smolińska; Joelle Dupont; Agnieszka Rak
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.